| Literature DB >> 30917121 |
Monica O Kuteesa1,2, Helen A Weiss2,3, Andrew Abaasa1,2, Stephen Nash2,3, Rebecca N Nsubuga1, Rob Newton1, Janet Seeley1,2, Anatoli Kamali4.
Abstract
OBJECTIVE: We assessed feasibility of an HIV-combination-prevention trial among fishing communities in Uganda.Entities:
Mesh:
Year: 2019 PMID: 30917121 PMCID: PMC6436767 DOI: 10.1371/journal.pone.0210719
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Fig 1Map showing the intervention and control study region and communities.
Fig 2Consort flow.
Baseline characteristics of adults in a pilot HIV combination prevention community randomised control trial among fishing communities along the shores of Lake Victoria, Uganda (May 2014).
| Control villages | Intervention villages | |||
|---|---|---|---|---|
| Outcome | Village 1 | Village 2 | Village 3 | Village 4 |
| 211 | 207 | 201 | 241 | |
| Urban | Rural | Urban | Rural | |
| 108 / 211 (51.2%) | 124 / 207 (59.9%) | 81 / 201 (40.3%) | 124 / 241 (51.5%) | |
| 103 / 211 (48.8%) | 83 / 207 (40.1%) | 120 / 201 (59.7%) | 117 / 241 (48.5%) | |
| 66 / 211 (31.3%) | 72 / 207 (34.8%) | 88 / 201 (43.8%) | 90 / 241 (37.3%) | |
| 80 / 211 (37.9%) | 82 / 207 (39.6%) | 63 / 201 (31.3%) | 86 / 241 (35.7%) | |
| 65 / 211 (30.8%) | 53 / 207 (25.6%) | 50 / 201 (24.9%) | 65 / 241 (27.0%) | |
| 52 / 208 (25.0%) | 43 / 206 (20.9%) | 48 / 200 (24.0%) | 46 / 237 (19.4%) | |
| 32 / 196 (16.3%) | 17 / 132 (12.9%) | 23 / 195 (11.8%) | 15 / 155 (9.7%) | |
| 99 / 196 (50.5%) | 90 / 132 (68.2%) | 85 / 195 (43.6%) | 92 / 155 (59.4%) | |
| 55 / 196 (28.1%) | 24 / 132 (18.2%) | 62 / 195 (31.8%) | 42 / 155 (27.1%) | |
| 10 / 196 (5.1%) | 1 / 132 (0.8%) | 25 / 195 (12.8%) | 6 / 155 (3.9%) | |
| 175 / 211 (82.9%) | 162 / 207 (78.3%) | 157 / 201 (78.1%) | 204 / 241 (84.6%) | |
| 38 / 211 (18.0%) | 38 / 207 (18.4%) | 22 / 201 (10.9%) | 40 / 241 (16.6%) | |
| 1.21 (0.9) | 1.14 (0.7) | 1.19 (1.7) | 1.19 (2.1) | |
| 18 / 188 (9.6%) | 16 / 189 (8.5%) | 21 / 169 (12.4%) | 22 / 218 (10.1%) | |
| 37 / 102 (36.3%) | 47 / 111 (42.3%) | 50 / 78 (64.1%) | 58 / 114 (50.9%) | |
‡ 9 missing values
‡‡ (183 missing values)
*4 missing values
**96 missing values
†32 missing values
Process evaluation for interventions.
| Intervention delivered | Control | Intervention | Overall |
|---|---|---|---|
| 23,040 | 74,540 | 97,580 male condoms | |
| 1524 | 2380 | 3904 | |
| 135 | 210 | 345 | |
| 109 | 541 | 650 |
* Roll out of VMMC in the control sites coincided with changes in national policy and WHO VMMC and Tetanus vaccination guidelines. We provided 247 men in the control arm three doses of TT vaccination prior to VMMC, 54% were circumcised.
Loss to follow-up (LTFU) of study participants from baseline to endline.
| Characteristic | Total | Lost | Crude Odds Ratio of being LTFU (95% CI) |
|---|---|---|---|
| 412 | 99 (24.0%) | Baseline | |
| 448 | 87 (19.4%) | 0.76 (0.55, 1.05) | |
| 437 | 83 (19.0%) | Baseline | |
| 423 | 103 (24.3%) | 1.37 (0.99, 1.90) | |
| 316 | 88 (27.8%) | Baseline | |
| 311 | 64 (20.6%) | 0.67 (0.46, 0.97) | |
| 233 | 34 (14.6%) | 0.44 (0.29, 0.69) | |
| 189 | 52 (27.5%) | Baseline | |
| 662 | 132 (19.9%) | 0.66 (0.45, 0.95) | |
| 117 | 47 (40.2%) | Baseline | |
| 743 | 139 (18.7%) | 0.34 (0.23, 0.52) | |
| 87 | 17 (19.5%) | 0.84 (0.47, 1.51) | |
| 366 | 82 (22.4%) | Baseline | |
| 183 | 49 (26.8%) | 1.27 (0.84, 1.91) | |
| 42 | 9 (21.4%) | 0.94 (0.43, 2.05) | |
| 551 | 130 (23.6%) | Baseline | |
| 309 | 56 (18.1%) | 0.72 (0.51, 1.02) | |
| 639 | 149 (23.3%) | Baseline | |
| 221 | 37 (16.7%) | 0.66 (0.44, 0.98) | |
| 782 | 159 (20.3%) | Baseline | |
| 78 | 27 (34.6%) | 2.07 (1.26, 3.41) | |
| 162 | 41 (25.3%) | Baseline | |
| 698 | 145 (20.8%) | 0.77 (0.52, 1.15) | |
| 722 | 143 (19.8%) | Baseline | |
| 138 | 43 (31.2%) | 1.83 (1.22, 2.75) | |
| 687 | 144 (21.0%) | Baseline | |
| 77 | 16 (20.8%) | 0.99 (0.55, 1.77) | |
| 214 | 45 (21.0%) | Baseline | |
| 191 | 38 (19.9%) | 0.93 (0.57, 1.51) | |
| 418 | 88 (21.1%) | Baseline | |
| 442 | 98 (22.2%) | 1.07 (0.77, 1.48) | |
Uptake of HIV prevention methods.
| Outcome | Control villages | Intervention villages | ||
|---|---|---|---|---|
| Village 1 | Village 2 | Village 3 | Village 4 | |
| Baseline | 92 (43.6%) | 89 (43.0%) | 87 (43.3%) | 88 (36.5%) |
| Round 2 | 36 (25.9%) | 48 (30.8%) | 58 (42.0%) | 54 (30.0%) |
| Round 3 | 30 (22.1%) | 49 (34.5%) | 44 (36.7%) | 54 (34.8%) |
| Baseline | 118 (55.9%) | 103 (49.8%) | 105 (52.2%) | 140 (58.1%) |
| Round 2 | 99 (71.2%) | 95 (60.9%) | 80 (58.0%) | 115 (63.9%) |
| Round 3 | 104 (76.5%) | 98 (69.0%) | 82 (68.3%) | 101 (65.2%) |
| Baseline | 37 (36.3%) | 47 (42.3%) | 50 (64.1%) | 58 (50.9%) |
| Round 2 | 27 (40.3%) | 47 (51.1%) | 46 (79.3%) | 60 (66.7%) |
| Round 3 | 21 (34.4%) | 43 (56.6%) | 45 (86.5%) | 50 (70.4%) |
| Baseline | 175 (83.7%) | 180 (87.8%) | 172 (86.4%) | 207 (86.3%) |
| Round 2 | 137 (100.0%) | 155 (100.0%) | 137 (100.0%) | 175 (100.0%) |
| Round 3 | 131 (99.2%) | 138 (100.0%) | 118 (100.0%) | 152 (100.0%) |